Pharmacogenetics of Hypoglycemia Associated with Sulfonylurea Therapy in Usual Clinical Care

Hypoglycemia is a common complication among type 2 diabetes mellitus (T2DM) patients receiving sulfonylurea therapy. The aim of this study was to determine if genetic contributions to sulfonylurea pharmacokinetics or pharmacodynamics substantially affect the risk of hypoglycemia in these patients. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Sabrina L, Carranza Leon, Daniel A, Chaugai, Sandip, Kawai, Vivian K, Levinson, Rebecca T, Wei, Wei-Qi, Stein, C Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174577/
https://www.ncbi.nlm.nih.gov/pubmed/32504053
http://dx.doi.org/10.1038/s41397-020-0171-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174577/
https://www.ncbi.nlm.nih.gov/pubmed/32504053
http://dx.doi.org/10.1038/s41397-020-0171-4

Ejemplares similares